Calgary, Canada

Saurav Roy Choudhury

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 8.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Saurav Roy Choudhury: Innovator in Pharmaceutical Compositions

Introduction

Saurav Roy Choudhury is a notable inventor based in Calgary, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions aimed at reducing inflammation and treating various medical conditions. With a total of 3 patents, his work is recognized for its potential impact on healthcare.

Latest Patents

Choudhury's latest patents include innovative pharmaceutical compositions and methods of use that focus on reducing inflammation in subjects. His work on DPEP-1 binding compositions provides methods for blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis, and preventing or reducing acute kidney injury. Additionally, he has developed DPEP-1 binding agents that offer similar therapeutic benefits, showcasing his commitment to advancing medical science.

Career Highlights

Saurav Roy Choudhury is currently associated with Arch Biopartners, Inc., where he continues to push the boundaries of pharmaceutical research. His expertise and dedication to innovation have positioned him as a key player in the industry.

Collaborations

Choudhury collaborates with esteemed colleagues such as Stephen Mark Robbins and Donna Lorraine Senger, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Saurav Roy Choudhury's work in pharmaceutical compositions exemplifies the spirit of innovation in the medical field. His contributions are paving the way for new treatments that could significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…